Please assess the completion status of the following clinical trial:

Trial Title: Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically or cytologically documented NSCLC.~* Candidate for primary chemoradiation as decided by both medical and radiation oncology.~* Cancer should be staged via AJCC as IIIA or IIIB.~* Stage IV patients are considered provided they have a single non-CNS metastasis (that is amenable to treatment with radiation therapy).~* Age ≥ 18 years~* ECOG performance status 0-2 (Karnofsky \> 50%, see Appendix A).~* Hypertensive medication should be initiated or increased for optimal blood pressure control according to standard public health guidelines prior to starting the ketogenic diet.~* Patients must have normal organ and marrow function as defined below:~* leukocytes ≥ 3,000/mm3~* absolute neutrophil count ≥ 1,500/mm3~* platelets ≥ 100,000/mm3~* total bilirubin \< 1.5 mg/dl~* Hgb A1C \< or = to 8%~* AST(SGOT) \< or = to 2 X institutional upper limit of normal~* creatinine \< 1.5 X institutional upper limit of normal OR creatinine clearance ≥ 60 mL/min/1.73 m2 for patients with creatinine levels above institutional normal.~* Not pregnant. Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.~* Ability to understand and the willingness to sign a written informed consent document.~Exclusion Criteria:~* Life expectancy of 3 or less months.~* Prior thoracic radiotherapy.~* Prior therapy, with the intent to treat, the current diagnosis of lung cancer.~* Known G6PD (glucose-6-phosphate dehydrogenase) deficiency.~* Systemic corticosteroids for any reason (inhaled corticosteroids are allowed).~* Other investigational agents/therapy with the intention to treat the disease under study (observational or imaging trials are acceptable).~* Uncontrolled diabetes defined as a hemoglobin A1C level \> 8% (therapeutic action is indicated at greater than 8%).~* Diabetes is not exclusionary provided the patient is not maintained with either oral medications or insulin.~* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements as determined by study team members.~* Pregnant or lactating women: The risks of radiation and chemotherapy to a fetus are well documented.~Female and male patients of all ethnic groups will be eligible for treatment in these protocols.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ketogenic diet (Type: EXPERIMENTAL): Diet formulated to maintain elevated ketones during therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues